ArticleNature communications2014
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.
Rajat Banerjee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
102 papers cite itlatest 60 shown
this papercites it